tiprankstipranks
Vection Technologies’ AI Assistant Trials at MGH
Company Announcements

Vection Technologies’ AI Assistant Trials at MGH

Vection Technologies Ltd. (AU:VR1) has released an update.

Stay Ahead of the Market:

Vection Technologies Ltd. has announced that their AI-powered 3D virtual assistant, Katherine, is undergoing full-scale trials at Massachusetts General Hospital. This innovative tool is part of the Raising Healthy Hearts program, aimed at enhancing patient data collection and care planning in pediatric cardiology, with potential for broader adoption. The strategic milestone highlights Katherine’s ability to streamline healthcare operations and improve patient outcomes through a scalable pricing model.

For further insights into AU:VR1 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles